These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33797702)

  • 41. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice.
    Pontrelli P; Conserva F; Menghini R; Rossini M; Stasi A; Divella C; Casagrande V; Cinefra C; Barozzino M; Simone S; Pesce F; Castellano G; Stallone G; Gallone A; Giorgino F; Federici M; Gesualdo L
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit.
    He X; Zhang K; Gao X; Li L; Tan H; Chen J; Zhou Y
    Heart Vessels; 2016 Oct; 31(10):1696-708. PubMed ID: 26968995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
    Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
    J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-150-5p Alleviates Renal Tubule Epithelial Cell Fibrosis via the Inhibition of Epithelial-Mesenchymal Transition by Targeting ZEB1.
    Zhang Z; Zhang X; Gao X; Fang B; Tian S; Kang P; Zhao Y
    Int Arch Allergy Immunol; 2024; 185(9):827-835. PubMed ID: 38763133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1.
    Mu J; Pang Q; Guo YH; Chen JG; Zeng W; Huang YJ; Zhang J; Feng B
    PLoS One; 2013; 8(3):e58622. PubMed ID: 23554908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).
    Yu D; Yang X; Zhu Y; Xu F; Zhang H; Qiu Z
    Endocr J; 2021 May; 68(5):519-529. PubMed ID: 33408314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
    Fu JX; Sun GQ; Wang HL; Jiang HX
    J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
    Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
    J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.
    Yiu WH; Li RX; Wong DWL; Wu HJ; Chan KW; Chan LYY; Leung JCK; Lai KN; Sacks SH; Zhou W; Tang SCW
    Nephrol Dial Transplant; 2018 Aug; 33(8):1323-1332. PubMed ID: 29294056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin Ameliorates Renal Fibrosis Through the Inhibition of NF-κB and TGF-β1/Smad3 Pathways in db/db Diabetic Mice.
    Fan Z; Qi X; Yang W; Xia L; Wu Y
    Arch Med Res; 2020 Aug; 51(6):524-534. PubMed ID: 32473749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway.
    Liu L; Pang X; Shang W; Feng G; Wang Z; Wang J
    Ren Fail; 2020 Nov; 42(1):513-522. PubMed ID: 32441195
    [No Abstract]   [Full Text] [Related]  

  • 53. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
    Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
    Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
    Zhao D; Jia J; Shao H
    J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
    Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
    Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.
    Ka SM; Yeh YC; Huang XR; Chao TK; Hung YJ; Yu CP; Lin TJ; Wu CC; Lan HY; Chen A
    Diabetologia; 2012 Feb; 55(2):509-19. PubMed ID: 22086159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of centella asiatica granule on the expression of TGF-β
    Ma JW; Wang HT; Liu HF; Ding Y; Bai JQ; Zhang Z
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):69-73. PubMed ID: 29926663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of enalapril on the expression of TGF-beta1, p-Smad2/3 and Smad7 in renal interstitial fibrosis in rats].
    Ning W; Tao L; Liu C; Sun J; Xiao Y; Hu J; Chen J; Zheng X; Wang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):27-34. PubMed ID: 19197123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
    Ai K; Zhu X; Kang Y; Li H; Zhang L
    Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p/P311/TGF-β1 pathway.
    Du Y; Yang YT; Tang G; Jia JS; Zhu N; Yuan WJ
    FASEB J; 2020 Aug; 34(8):10462-10475. PubMed ID: 32539181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.